D'Cruz DP - Search Results

1

The safety of mycophenolate mofetil in pregnancy.

Pisoni CN, D'Cruz DP. Pisoni CN, et al. Expert Opin Drug Saf. 2008 May;7(3):219-22. doi: 10.1517/14740338.7.3.219. Expert Opin Drug Saf. 2008. PMID: 18462179

2

Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.

Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR. Pisoni CN, et al. J Rheumatol. 2005 Jun;32(6):1047-52. J Rheumatol. 2005. PMID: 15940766

3

Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.

Karim MY, Pisoni CN, Ferro L, Tungekar MF, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GR. Karim MY, et al. Rheumatology (Oxford). 2005 Oct;44(10):1317-21. doi: 10.1093/rheumatology/kei019. Epub 2005 Jul 27. Rheumatology (Oxford). 2005. PMID: 16049051

4

Mycophenolate mofetil treatment in resistant myositis.

Pisoni CN, Cuadrado MJ, Khamashta MA, Hughes GR, D'Cruz DP. Pisoni CN, et al. Rheumatology (Oxford). 2007 Mar;46(3):516-8. doi: 10.1093/rheumatology/kel336. Epub 2006 Sep 26. Rheumatology (Oxford). 2007. PMID: 17003173

5

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.

Karim MY, Alba P, Cuadrado MJ, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GR. Karim MY, et al. Rheumatology (Oxford). 2002 Aug;41(8):876-82. doi: 10.1093/rheumatology/41.8.876. Rheumatology (Oxford). 2002. PMID: 12154204 Clinical Trial.

6

Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil.

Bennett AN, Peterson P, Sangle S, Hangartner R, Abbs IC, Hughes GR, D'Cruz DP. Bennett AN, et al. Rheumatology (Oxford). 2004 Jun;43(6):795-9. doi: 10.1093/rheumatology/keh172. Epub 2004 Mar 23. Rheumatology (Oxford). 2004. PMID: 15039497

7

Mycophenolate mofetil in systemic vasculitis.

D'Cruz DP. D'Cruz DP. Lupus. 2005;14 Suppl 1:s55-7. doi: 10.1191/0961203305lu2120oa. Lupus. 2005. PMID: 15803934 Review.

8

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group. Appel GB, et al. J Am Soc Nephrol. 2009 May;20(5):1103-12. doi: 10.1681/ASN.2008101028. Epub 2009 Apr 15. J Am Soc Nephrol. 2009. PMID: 19369404 Free PMC article. Clinical Trial.

9

Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.

Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA; ALMS Group. Ginzler EM, et al. Arthritis Rheum. 2010 Jan;62(1):211-21. doi: 10.1002/art.25052. Arthritis Rheum. 2010. PMID: 20039429 Free article. Clinical Trial.

10

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R; MAINTAIN Nephritis Trial Group. Houssiau FA, et al. Ann Rheum Dis. 2010 Dec;69(12):2083-9. doi: 10.1136/ard.2010.131995. Epub 2010 Sep 10. Ann Rheum Dis. 2010. PMID: 20833738 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page